Cargando…
Androgen Deprivation Therapy Reversibly Increases Endothelium‐Dependent Vasodilation in Men With Prostate Cancer
BACKGROUND: Androgen deprivation therapy (ADT) is a standard treatment for patients with aggressive prostate cancer. Although ADT improves survival, it increases the risk of diabetes. Emerging evidence suggests that ADT increases adverse cardiovascular events as early as 3 months after initiation in...
Autores principales: | Nguyen, Paul L., Jarolim, Petr, Basaria, Shehzad, Zuflacht, Jonah P., Milian, Jessica, Kadivar, Samoneh, Graham, Powell L., Hyatt, Andrew, Kantoff, Philip W., Beckman, Joshua A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579953/ https://www.ncbi.nlm.nih.gov/pubmed/25896892 http://dx.doi.org/10.1161/JAHA.115.001914 |
Ejemplares similares
-
Cardiometabolic and Skeletal Risk Factors in Black Men with Prostate Cancer Starting Androgen Deprivation Therapy
por: Gunnarsson, Orvar, et al.
Publicado: (2015) -
Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018) -
Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study
por: Braga-Basaria, Milena, et al.
Publicado: (2023) -
Testosterone Therapy for Men With Age-Related Low Testosterone: Tempest in a Teacup
por: Basaria, Shehzad
Publicado: (2021) -
Post-exercise Endothelium-Dependent Vasodilation Is Dependent on Training Status
por: Kapilevich, L. V., et al.
Publicado: (2020)